Abstract | PURPOSE: EXPERIMENTAL DESIGN: RESULTS: CONCLUSIONS: Our results are significant and clinically relevant as they provide the first biomarker of asbestos exposure and indicate that hyperacetylated HMGB1 is an accurate biomarker to differentiate malignant mesothelioma patients from individuals occupationally exposed to asbestos and unexposed controls. A trial to independently validate these findings will start soon. Clin Cancer Res; 22(12); 3087-96. ©2016 AACR.
|
Authors | Andrea Napolitano, Daniel J Antoine, Laura Pellegrini, Francine Baumann, Ian Pagano, Sandra Pastorino, Chandra M Goparaju, Kirill Prokrym, Claudia Canino, Harvey I Pass, Michele Carbone, Haining Yang |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 22
Issue 12
Pg. 3087-96
(06 15 2016)
ISSN: 1557-3265 [Electronic] United States |
PMID | 26733616
(Publication Type: Journal Article)
|
Copyright | ©2016 American Association for Cancer Research. |
Chemical References |
- Biomarkers
- EFEMP1 protein, human
- Extracellular Matrix Proteins
- GPI-Linked Proteins
- HMGB1 Protein
- HMGB1 protein, human
- SPP1 protein, human
- Osteopontin
- Asbestos
- Mesothelin
|
Topics |
- Acetylation
- Adult
- Aged
- Asbestos
(blood, toxicity)
- Biomarkers
(blood)
- Environmental Exposure
- Extracellular Matrix Proteins
(blood)
- Female
- GPI-Linked Proteins
(blood)
- HMGB1 Protein
(blood, metabolism)
- Humans
- Lung Neoplasms
(blood, diagnosis)
- Male
- Mesothelin
- Mesothelioma
(blood, diagnosis)
- Mesothelioma, Malignant
- Middle Aged
- Osteopontin
(blood)
- Pleural Effusion
(blood, diagnosis)
- Pleural Neoplasms
(blood, diagnosis)
- Sensitivity and Specificity
- Young Adult
|